<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="brief-report"><?DTDIdentifier.IdentifierValue http://null/schema/dtds/document/fulltext/xcr/xocs-article.xsd?><?DTDIdentifier.IdentifierType schema?><?SourceDTD.DTDName xocs-article.xsd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName ftrr2jats.xsl?><?ConverterInfo.Version 1?><?origin publisher?><front><journal-meta><journal-id journal-id-type="nlm-ta">Med Drug Discov</journal-id><journal-id journal-id-type="iso-abbrev">Med Drug Discov</journal-id><journal-title-group><journal-title>Medicine in Drug Discovery</journal-title></journal-title-group><issn pub-type="epub">2590-0986</issn><publisher><publisher-name>Published by Elsevier B.V.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7266578</article-id><article-id pub-id-type="publisher-id">S2590-0986(20)30038-5</article-id><article-id pub-id-type="doi">10.1016/j.medidd.2020.100051</article-id><article-id pub-id-type="publisher-id">100051</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Vitamin D Levels and COVID-19 Susceptibility: Is there any Correlation?</article-title></title-group><contrib-group><contrib contrib-type="author" id="au0005"><name><surname>Razdan</surname><given-names>Karan</given-names></name><xref rid="af0005" ref-type="aff">a</xref></contrib><contrib contrib-type="author" id="au0010"><name><surname>Singh</surname><given-names>Kuldeep</given-names></name><xref rid="af0010" ref-type="aff">b</xref></contrib><contrib contrib-type="author" id="au0015"><name><surname>Singh</surname><given-names>Dilpreet</given-names></name><email>dilpreet.daman@gmail.com</email><xref rid="af0015" ref-type="aff">c</xref><xref rid="cr0005" ref-type="corresp">&#x0204e;</xref></contrib><aff id="af0005"><label>a</label>University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh, India</aff><aff id="af0010"><label>b</label>Department of Pharmaceutical Sciences and Drug Research, Punjabi University Patiala, India</aff><aff id="af0015"><label>c</label>Department of Pharmaceutical Sciences, Guru Nanak Dev University, Amritsar, India</aff></contrib-group><author-notes><corresp id="cr0005"><label>&#x0204e;</label>Corresponding author at: Department of Pharmaceutical Sciences, Guru Nanak Dev University Amritsar. <email>dilpreet.daman@gmail.com</email></corresp></author-notes><pub-date pub-type="pmc-release"><day>2</day><month>6</month><year>2020</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.--><pub-date pub-type="ppub"><month>9</month><year>2020</year></pub-date><pub-date pub-type="epub"><day>2</day><month>6</month><year>2020</year></pub-date><volume>7</volume><fpage>100051</fpage><lpage>100051</lpage><history><date date-type="received"><day>3</day><month>5</month><year>2020</year></date><date date-type="rev-recd"><day>26</day><month>5</month><year>2020</year></date><date date-type="accepted"><day>26</day><month>5</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; 2020 Published by Elsevier B.V.</copyright-statement><copyright-year>2020</copyright-year><copyright-holder/><license><license-p>Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.</license-p></license></permissions><abstract id="ab0005"><p>Coronavirus disease (COVID-19) is a major pandemic and now a leading cause of death worldwide. Currently, no drugs/vaccine is available for the treatment of this disease. Future preventions and social distancing are the only ways to prevent this disease from community transmission. Vitamin D is an important micronutrient and has been reported to improve immunity and protect against respiratory illness. This short review highlights the important scientific link between Vitamin D levels and susceptibility to COVID-19 in patients. This review also discusses recommendations for Vitamin D dose required for healthy as well as COVID-19 susceptible patients for protection and prevention.</p></abstract><abstract abstract-type="author-highlights" id="ab0010"><title>Highlights</title><p><list list-type="simple" id="l0005"><list-item id="li0005"><label>&#x02022;</label><p id="p0005">COVID-19 is a pandemic outbreak affecting people globally.</p></list-item><list-item id="li0010"><label>&#x02022;</label><p id="p0010">Vitamin D supplementation could increase the immunity and decrease the COVID-19 susceptibility</p></list-item><list-item id="li0015"><label>&#x02022;</label><p id="p0015">The mechanisms linking Vitamin D levels and immune system have been described in this review</p></list-item></list></p></abstract><kwd-group id="ks0005"><title>Keywords</title><kwd>COVID-19</kwd><kwd>Vitamin D</kwd><kwd>VDR</kwd><kwd>Dose</kwd></kwd-group></article-meta></front><body><sec id="s0005"><label>1</label><title>Introduction</title><p id="p0020">A third wave of coronavirus (CoV) infections has swept the world and brought it to its knees. This new CoV infection called as COVID-19 originated in Wuhan, Hubei Province, China in December 2019 [<xref rid="bb0005" ref-type="bibr">1</xref>]. The causative agent for this respiratory illness is severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) [<xref rid="bb0010" ref-type="bibr">2</xref>]. Previous epidemics of coronavirus include severe acute respiratory syndrome (SARS), which originated in China in 2002 [<xref rid="bb0015" ref-type="bibr">3</xref>] and the ongoing Middle East respiratory syndrome (MERS),) first recorded in 2012 in the Middle East [<xref rid="bb0020" ref-type="bibr">4</xref>]. These epidemics have a high infection transmission rate and in general, the direct cause of death is severe atypical pneumonia [<xref rid="bb0025" ref-type="bibr">5</xref>]. The disease spread rapidly from the initial epicenter, Wuhan to rest of the world and has become a pandemic. A total number of 53,07,298 COVID-19 cases have been confirmed as of 25 May 2020 and more than 342,000 cases of deaths have been reported worldwide [<xref rid="bb0030" ref-type="bibr">6</xref>]. The main risk factors include pneumonia, acute kidney failure, acute heart failure. The global COVID-19 outbreak has placed devastating impact on every community. People with underlying health conditions such as cardiovascular disease, diabetes, chronic respiratory disease and the elderly above 60 years are most susceptible to COVID-19. There is currently no treatment available although vaccine development is under progress. This has led many researchers and clinicians to look for alternate or drug repurposing strategies that can lower the number of active COVID-19 cases and lead to subsequent reduction in the mortality rate.</p><p id="p0025">Vitamin D (Vit D) is a fat-soluble vitamin that plays major role in calcium homeostasis. It is synthesized endogenously in the skin when exposed to Ultraviolet-B (UV-B) radiations in sunlight. 1,25-dihydroxy vitamin D [1,25-(OH)<sub>2</sub> D] is the active form of Vit D [<xref rid="bb0035" ref-type="bibr">7</xref>]. Our body&#x02019;s innate and adaptive immune system provides protection against viral infections and aids in regulating cytokine levels in young and elderly populations, respectively. Vit D has been widely implicated in enhancing the immune response and suppressing the cytokine storm [<xref rid="bb0040" ref-type="bibr">8</xref>]. It&#x02019;s deficiency has been linked to increased susceptibility to viral infections [<xref rid="bb0045" ref-type="bibr">9</xref>]. In this short review, we hypothesize that correlation exists between vitamin D levels and susceptibility to COVID-19, and Vit D supplementation could decrease the risk and severity of COVID-19.</p></sec><sec id="s0010"><label>2</label><title>Mechanism for regulation of immunity in viral infections by Vitamin D</title><p id="p0030">Immune cells have been known to express vitamin D receptors (VDR) and various immune cells (monocytes, dendritic cells, macrophages, B cells and T cells) are capable of converting 25-hydroxy Vit D (25OHD) into active form 1,25-(OH)<sub>2</sub> D. This permits local regulation of the 1,25-(OH)<sub>2</sub> D at the site of inflammation [<xref rid="bb0050" ref-type="bibr">10</xref>]. Binding of 1,25-(OH)<sub>2</sub> D to the VDR leads to translocation of the complex into the cell nucleus where it modifies the expression of hundreds of genes, including those for cytokine production [<xref rid="bb0055" ref-type="bibr">11</xref>]. The complex also induces the production of antimicrobial peptides including cathelicidin and defensins [<xref rid="bb0060" ref-type="bibr">12</xref>]. A study by Zhao et al [<xref rid="bb0065" ref-type="bibr">13</xref>] showed reduction in the replication of rotavirus both <italic>in vitro</italic> and <italic>in vivo</italic> by administration of Vit D at dose of 5000 IU/kg. Induction of cytokine storm is reduced by Vit D. The innate immune system generates both pro-inflammatory and anti-inflammatory cytokines in patients suffering from COVID-19 [<xref rid="bb0070" ref-type="bibr">14</xref>]. Vit D can decrease the production of T helper cell type 1 (Th1) cytokines such as interferon-&#x003b3; and tumor necrosis factor-&#x003b1; (TNF-&#x003b1;) [<xref rid="bb0075" ref-type="bibr">15</xref>]. Also, expression of pro-inflammatory cytokines by macrophages is reduced and anti-inflammatory cytokines is increased by Vit D administration [<xref rid="bb0080" ref-type="bibr">16</xref>].</p><p id="p0035">Binding to dipeptidyl peptidase-4 receptor (DPP-4/CD26) is one of the molecular virulence mechanisms employed by CoV [<xref rid="bb0085" ref-type="bibr">17</xref>]. It has been demonstrated recently that human DPP-4/CD26 interacts with the S1 domain of SARS-COV-2 spike glycoprotein [<xref rid="bb0090" ref-type="bibr">18</xref>]. In this context, fulfilment of Vit D deficiency has been shown to remarkably reduce expression of DPP4/CD26 receptor <italic>in vivo</italic> [<xref rid="bb0095" ref-type="bibr">19</xref>]. Vit D has been demonstrated to be a strong inducer of autophagy [<xref rid="bb0100" ref-type="bibr">20</xref>] and study by Campbell et al [<xref rid="bb0105" ref-type="bibr">21</xref>] reported inhibition of HIV replication in macrophages via VitD-mediated induction of cathelicidin, perhaps by enhancing autophagy and phagosomal maturation.</p></sec><sec id="s0015"><label>3</label><title>Role of Vitamin D deficiency in COVID-19 and dose recommendations</title><p id="p0040">Vit D deficiency is a global health problem common among all age groups [<xref rid="bb0110" ref-type="bibr">22</xref>]. Negligible UV-B radiations reach the earth surface during winters at latitudes &#x0003e; 40&#x000b0;. This increases the risk of Vit D deficiency during wintertime [<xref rid="bb0110" ref-type="bibr">22</xref>]. Epidemiological evidence suggests that during first month of winter, influenza infection is most common worldwide when Vit D levels are at their minimum [<xref rid="bb0115" ref-type="bibr">23</xref>]. Sufficient Vit D levels have shown to safeguard against influenza and respiratory syncytial virus (RSV) infections [<xref rid="bb0120" ref-type="bibr">24</xref>]. Also, serum 25-hydroxy Vit D levels tend to drop with age [<xref rid="bb0125" ref-type="bibr">25</xref>]. This is important with regard to COVID-19 as case-fatality rates (CFRs) surge with age [<xref rid="bb0130" ref-type="bibr">26</xref>]. Bergman et al [<xref rid="bb0135" ref-type="bibr">27</xref>] conducted a meta analysis of randomized controlled trials (RCT) of Vit D for prevention of respiratory tract infection (RTI). They demonstrated that risk of developing RTIs is reduced by prophylactic administration of Vit D (odds ratio: 0.64; 95% CI: 0.49 to 0.84). Rhodes et al [<xref rid="bb0140" ref-type="bibr">28</xref>] highlighted relationship between mortality from COVID-19 per million of population and countries based on their latitudes. It was observed that countries lying below 35&#x000b0; North latitude have low mortality rates. This could be attributed to the fact that people living in countries lying above 35&#x000b0; North do not encounter adequate sunlight during winter and suffer from Vit D deficiency. Likewise, Daneshkhah et al [<xref rid="bb0145" ref-type="bibr">29</xref>] showed that the age-specific case fatality rate (CFR) of COVID-19 was highest in Italy, Spain, and France where severe Vit D deficiency (mean 25OHD concentration &#x0003c; 0.25 ng/L) is reported in comparison to other countries. In elderly population, overactivation of adaptive immune system results from a shortage of memory B cells and aberrant innate immune response, which leads to cytokine storm as observed in COVID-19 patients [<xref rid="bb0150" ref-type="bibr">30</xref>]. In another study, Lau et al [<xref rid="bb0155" ref-type="bibr">31</xref>] assessed 25OHD levels in twenty COVID-19 patients admitted in intesive care unit (ICU). 11 subjects had Vit D insufficiency (VID) and all patients below 75 years of age had VDI. Among these, 7 patients had &#x0003c;20 ng/mL and three had &#x0003c; 10 ng/mL of 25OHD levels. This study demonstrated that VDI intensifies COVID-19 severity. A retrospective multinomial logistic regression study by Alipio [<xref rid="bb0160" ref-type="bibr">32</xref>] on data of 212 COVID-19 patients in south-Asian countries, suggests that increase in serum 25OHD levels could improve clinical outcomes. Statistical analysis was carried out using Mann-Whitney U and &#x003c7;<sup>2</sup> tests. As the severity of disease increased from mild to critical, serum 25OHD levels decreased from 31.2 ng/ml to 17.1 ng/ml and were statistically significant with clinical outcomes (p&#x0003c;0.001). Out of 212 patients, 80 exhibited Vit D insufficiency (25 OHD&#x0003c; 21-29 ng/ml) and 77 exhibited Vit D deficiency (25 OHD&#x0003c; 20 ng/ml). The odds of having mild clinical outcome increases and critical outcome decreases (OR=0.051, p&#x0003c;0.001), with increase in serum 25 OHD level.</p><p id="p0045">Above mentioned studies clearly indicate that having Vit D deficiency predisposes sensitive population (elderly and individuals with underlying health conditions) to an attack by it&#x02019;s own immune system and exacerbate the RTI by damaging the lung tissue. Therefore, in order to maintain an appropriate Vit D status and reduce the mortality, supplementation is needed to restore the Vit D levels reduced due to inadequate exposure to sunlight. There is currently no scientific consensus about the optimal dose of Vit D supplementation for COVID-19. Currently, The Institute of Medicine has placed the recommended dietary allowance, or RDA, for vitamin D at 600 international units (IU) per day for young adults and 800 IU per day for adults older than 70 years [<xref rid="bb0165" ref-type="bibr">33</xref>]. But this recommendation was issued in context with bone health. Based on observational studies, concentrations of atleast 40-50 ng/mL are desired [<xref rid="bb0170" ref-type="bibr">34</xref>]. Another study reported that 38 ng/mL was suitable for reducing the risk of community acquired pneumonia [<xref rid="bb0175" ref-type="bibr">35</xref>]. In order to achieve the above concentration range, dose of 2000-5000 IU/day of Vit D<sub>3</sub> could be taken [<xref rid="bb0180" ref-type="bibr">36</xref>]. A study reported increase in 25OHD concentrations from 20 &#x000b1; 6 to 39 &#x000b1; 9 ng/mL for 4000 IU/day and from 19 &#x000b1; 4 to 67 &#x000b1; 3 ng/mL for 10,000 IU/day for 8 weeks administration of Vit D [<xref rid="bb0185" ref-type="bibr">37</xref>]. The U.S. Institute of Medicine noted that for daily doses of &#x0003c; 10,000 IU/day no adverse effects have been reported for Vit D supplementaion. However, the value for upper limit (UL) was corrected to 4000 IU/day based on all-cause mortality and chronic disease outcomes [<xref rid="bb0165" ref-type="bibr">33</xref>]. So, we recommend that keeping daily dose of Vit D below 4000 IU/day could be beneficial in improving the immunity to combat COVID-19 infection more effectively.</p></sec><sec id="s0020"><label>4</label><title>Conclusion</title><p id="p0050">Dearth of treatment for COVID-19 leaves us with no choice but to take precautionary and prophylactic measures to stand a better chance to fight this pandemic. Hence, maintaining adequate Vit D levels is vital to prevent getting infected or to ward off the infection without mortality, in case it occurs. Clinical trials should be conducted in regard to COVID-19 for assessing the effect of Vit D supplementation and determining the appropriate dose. We conclude that correlation exists between Vit D levels and COVID-19 susceptibility and Vit D could prove to be an essential element in our fight against COVID-19.</p></sec><sec id="s0025"><title>Credit author statement</title><p id="p0055">DS and KS conceived the idea for the paper. DS, KS and KR wrote the whole draft. KR edited the draft and approved for the final submission.</p></sec><sec sec-type="COI-statement" id="s0030"><title>Declaration of interest statement</title><p id="p0060">The authors hereby declare that they have no conflict of interest</p></sec><sec id="s1000"><title>Ethics Information</title><p id="p1000">No animals or human experiments were performed for this study</p></sec></body><back><ref-list id="bi0005"><title>References</title><ref id="bb0005"><label>1</label><element-citation publication-type="journal" id="rf0005"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>N.</given-names></name><name><surname>Zhang</surname><given-names>D.</given-names></name><name><surname>Wang</surname><given-names>W.</given-names></name></person-group><article-title>A Novel Coronavirus from Patients with Pneumonia in China, 2019</article-title><source>N Engl J Med</source><volume>328</volume><year>2020</year><fpage>727</fpage><lpage>733</lpage></element-citation></ref><ref id="bb0010"><label>2</label><element-citation publication-type="journal" id="rf0010"><person-group person-group-type="author"><name><surname>Gorbalenya</surname><given-names>E.A.</given-names></name></person-group><article-title>The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2, Nat</article-title><source>Microbiol.</source><volume>5</volume><year>2020</year><fpage>536</fpage><lpage>544</lpage></element-citation></ref><ref id="bb0015"><label>3</label><element-citation publication-type="journal" id="rf0015"><person-group person-group-type="author"><name><surname>Zhong</surname><given-names>N.S.</given-names></name><name><surname>Zheng</surname><given-names>B.J.</given-names></name><name><surname>Li</surname><given-names>Y.M.</given-names></name></person-group><article-title>Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People&#x02019;s Republic of China, in February, 2003</article-title><source>Lancet</source><volume>362</volume><year>2003</year><fpage>1353</fpage><lpage>1358</lpage><pub-id pub-id-type="pmid">14585636</pub-id></element-citation></ref><ref id="bb0020"><label>4</label><element-citation publication-type="journal" id="rf0020"><person-group person-group-type="author"><name><surname>Assiri</surname><given-names>A.</given-names></name><name><surname>McGeer</surname><given-names>A.</given-names></name><name><surname>Perl</surname><given-names>T.M.</given-names></name></person-group><article-title>Hospital outbreak of Middle East respiratory syndrome coronavirus</article-title><source>N Engl J Med</source><volume>369</volume><year>2013</year><fpage>407</fpage><lpage>416</lpage><pub-id pub-id-type="pmid">23782161</pub-id></element-citation></ref><ref id="bb0025"><label>5</label><element-citation publication-type="journal" id="rf0025"><person-group person-group-type="author"><name><surname>Yin</surname><given-names>Y.</given-names></name><name><surname>Wunderink</surname><given-names>R.G.</given-names></name></person-group><article-title>MERS, SARS and other coronaviruses as causes of pneumonia</article-title><source>Respirology</source><volume>23</volume><year>2018</year><fpage>130</fpage><lpage>137</lpage><pub-id pub-id-type="pmid">29052924</pub-id></element-citation></ref><ref id="bb0030"><label>6</label><element-citation publication-type="other" id="rf0030"><article-title>Coronavirus disease (COVID-19) outbreak situation</article-title><ext-link ext-link-type="uri" xlink:href="https://www.who.int/emergencies/diseases/novel-coronavirus-2019" id="ir0005">https://www.who.int/emergencies/diseases/novel-coronavirus-2019</ext-link></element-citation></ref><ref id="bb0035"><label>7</label><element-citation publication-type="journal" id="rf0035"><person-group person-group-type="author"><name><surname>Pilz</surname><given-names>S.</given-names></name><name><surname>M&#x000e4;rz</surname><given-names>W.</given-names></name><name><surname>Cashman</surname><given-names>K.D.</given-names></name></person-group><article-title>Rationale and plan for vitamin D food fortification: a review and guidance paper</article-title><source>Front Endocrinol</source><volume>9</volume><year>2018</year><fpage>1</fpage><lpage>16</lpage></element-citation></ref><ref id="bb0040"><label>8</label><element-citation publication-type="journal" id="rf0040"><person-group person-group-type="author"><name><surname>Khare</surname><given-names>D.</given-names></name><name><surname>Godbole</surname><given-names>N.M.</given-names></name><name><surname>Pawar</surname><given-names>S.D.</given-names></name></person-group><article-title>Calcitriol [1, 25[OH]2 D3] pre- and post-treatment suppresses inflammatory response to influenza A (H1N1) infection in human lung A549 epithelial cells</article-title><source>Eur J Nutr</source><volume>52</volume><year>2013</year><fpage>1405</fpage><lpage>1415</lpage><pub-id pub-id-type="pmid">23015061</pub-id></element-citation></ref><ref id="bb0045"><label>9</label><element-citation publication-type="journal" id="rf0045"><person-group person-group-type="author"><name><surname>Beard</surname><given-names>J.A.</given-names></name><name><surname>Bearden</surname><given-names>A.</given-names></name><name><surname>Striker</surname><given-names>R.</given-names></name></person-group><article-title>Vitamin D and the anti-viral state</article-title><source>J Clin Virol</source><volume>50</volume><year>2011</year><fpage>194</fpage><lpage>200</lpage><pub-id pub-id-type="pmid">21242105</pub-id></element-citation></ref><ref id="bb0050"><label>10</label><element-citation publication-type="journal" id="rf0050"><person-group person-group-type="author"><name><surname>Dankers</surname><given-names>W.</given-names></name><name><surname>Colin</surname><given-names>E.M.</given-names></name><name><surname>van Hamburg</surname><given-names>J.P.</given-names></name><name><surname>Lubberts</surname><given-names>E.</given-names></name></person-group><article-title>Vitamin D in autoimmunity: molecular mechanisms and therapeutic potential</article-title><source>Front Immunol</source><volume>7</volume><year>2017</year><fpage>1</fpage><lpage>26</lpage></element-citation></ref><ref id="bb0055"><label>11</label><element-citation publication-type="journal" id="rf0055"><person-group person-group-type="author"><name><surname>Takeuti</surname><given-names>F.A.</given-names></name></person-group><article-title>Souza-Fonseca-Guimaraes F, Guimaraes P.S, Applications of Vitamin D in Sepsis Prevention</article-title><source>Discov Med</source><volume>25</volume><year>2018</year><fpage>291</fpage><lpage>297</lpage><pub-id pub-id-type="pmid">30021102</pub-id></element-citation></ref><ref id="bb0060"><label>12</label><element-citation publication-type="journal" id="rf0060"><person-group person-group-type="author"><name><surname>Gombart</surname><given-names>A.F.</given-names></name><name><surname>Borregaard</surname><given-names>N.</given-names></name><name><surname>Koeffler</surname><given-names>H.P.</given-names></name></person-group><article-title>Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1, 25-dihydroxyvitamin D3</article-title><source>FASEB J</source><volume>19</volume><year>2005</year><fpage>1067</fpage><lpage>1077</lpage><pub-id pub-id-type="pmid">15985530</pub-id></element-citation></ref><ref id="bb0065"><label>13</label><element-citation publication-type="journal" id="rf0065"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>Y.</given-names></name><name><surname>Ran</surname><given-names>Z.</given-names></name><name><surname>Jiang</surname><given-names>Q.</given-names></name></person-group><article-title>Vitamin D Alleviates Rotavirus Infection through a Microrna-155-5p Mediated Regulation of the TBK1/IRF3 Signaling Pathway In Vivo and In Vitro</article-title><source>Int J Mol Sci</source><volume>20</volume><year>2019</year><fpage>1</fpage><lpage>17</lpage></element-citation></ref><ref id="bb0070"><label>14</label><element-citation publication-type="journal" id="rf0070"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>C.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name></person-group><article-title>Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China</article-title><source>Lancet</source><volume>395</volume><year>2020</year><fpage>497</fpage><lpage>506</lpage><pub-id pub-id-type="pmid">31986264</pub-id></element-citation></ref><ref id="bb0075"><label>15</label><element-citation publication-type="journal" id="rf0075"><person-group person-group-type="author"><name><surname>Sharifi</surname><given-names>A.</given-names></name><name><surname>Vahedi</surname><given-names>H.</given-names></name><name><surname>Nedjat</surname><given-names>S.</given-names></name><name><surname>Rafiei</surname><given-names>H.</given-names></name><name><surname>Hosseinzadeh-Attar</surname><given-names>M.J.</given-names></name></person-group><article-title>Effect of single dose injection of vitamin D on immune cytokines in ulcerative colitis patients: a randomized placebo-controlled trial</article-title><source>APMI.</source><volume>127</volume><year>2019</year><fpage>681</fpage><lpage>687</lpage></element-citation></ref><ref id="bb0080"><label>16</label><element-citation publication-type="journal" id="rf0080"><person-group person-group-type="author"><name><surname>Gombart</surname><given-names>A.F.</given-names></name><name><surname>Pierre</surname><given-names>A.</given-names></name><name><surname>Maggini</surname><given-names>S.</given-names></name></person-group><article-title>A Review of Micronutrients and the Immune System-Working in Harmony to Reduce the Risk of Infection</article-title><source>Nutrients.</source><volume>12</volume><year>2020</year><fpage>E236</fpage><pub-id pub-id-type="pmid">31963293</pub-id></element-citation></ref><ref id="bb0085"><label>17</label><element-citation publication-type="journal" id="rf0085"><person-group person-group-type="author"><name><surname>Skariyachan</surname><given-names>S.</given-names></name><name><surname>Challapilli</surname><given-names>S.B.</given-names></name><name><surname>Packirisamy</surname><given-names>S.</given-names></name><name><surname>Kumargowda</surname><given-names>S.T.</given-names></name><name><surname>Sridhar</surname><given-names>V.S.</given-names></name></person-group><article-title>Recent Aspects on the Pathogenesis Mechanism, Animal Models and Novel Therapeutic Interventions for Middle East Respiratory Syndrome Coronavirus Infections</article-title><source>Front Microbiol</source><volume>10</volume><year>2019</year><fpage>569</fpage><pub-id pub-id-type="pmid">30984127</pub-id></element-citation></ref><ref id="bb0090"><label>18</label><element-citation publication-type="journal" id="rf0090"><person-group person-group-type="author"><name><surname>Vankadari</surname><given-names>N.</given-names></name><name><surname>Wilce</surname><given-names>J.A.</given-names></name></person-group><article-title>Emerging WuHan (COVID-19) coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26</article-title><source>Emerg Microbes Infect</source><volume>9</volume><year>2020</year><fpage>601</fpage><lpage>604</lpage><pub-id pub-id-type="pmid">32178593</pub-id></element-citation></ref><ref id="bb0095"><label>19</label><element-citation publication-type="journal" id="rf0095"><person-group person-group-type="author"><name><surname>Komolmit</surname><given-names>P.</given-names></name><name><surname>Charoensuk</surname><given-names>K.</given-names></name><name><surname>Thanapirom</surname><given-names>K.</given-names></name></person-group><article-title>Correction of vitamin D deficiency facilitated suppression of IP-10 and DPP IV levels in patients with chronic hepatitis C: A randomised double-blinded, placebo-control trial</article-title><source>PLoS One</source><volume>12</volume><year>2017</year><object-id pub-id-type="publisher-id">e0174608</object-id></element-citation></ref><ref id="bb0100"><label>20</label><element-citation publication-type="journal" id="rf0100"><person-group person-group-type="author"><name><surname>Fabri</surname><given-names>M.</given-names></name><name><surname>Realegeno</surname><given-names>S.E.</given-names></name><name><surname>Jo</surname><given-names>E.K.</given-names></name><name><surname>Modlin</surname><given-names>R.L.</given-names></name></person-group><article-title>Role of autophagy in the host response to microbial infection and potential for therapy</article-title><source>Curr Opin Immunol</source><volume>23</volume><year>2011</year><fpage>65</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">21071195</pub-id></element-citation></ref><ref id="bb0105"><label>21</label><element-citation publication-type="journal" id="rf0105"><person-group person-group-type="author"><name><surname>Campbell</surname><given-names>G.R.</given-names></name><name><surname>Spector</surname><given-names>S.A.</given-names></name></person-group><article-title>Toll-like receptor 8 ligands activate a vitamin D mediated autophagic response that inhibits human immunodeficiency virus type 1</article-title><source>PLoS Pathog</source><volume>8</volume><year>2012</year><object-id pub-id-type="publisher-id">e1003017</object-id></element-citation></ref><ref id="bb0110"><label>22</label><element-citation publication-type="journal" id="rf0110"><person-group person-group-type="author"><name><surname>Palacios</surname><given-names>C.</given-names></name><name><surname>Gonzalez</surname><given-names>L.</given-names></name></person-group><article-title>Is vitamin D deficiency a major global health problem, J</article-title><source>Steroid Biochem Mol Biol</source><volume>144</volume><year>2014</year><fpage>138</fpage><lpage>145</lpage></element-citation></ref><ref id="bb0115"><label>23</label><element-citation publication-type="journal" id="rf0115"><person-group person-group-type="author"><name><surname>Cannell</surname><given-names>J.J.</given-names></name><name><surname>Vieth</surname><given-names>R.</given-names></name><name><surname>Umhau</surname><given-names>J.C.</given-names></name></person-group><article-title>Epidemic influenza and vitamin D</article-title><source>Epidemiol Infect</source><volume>134</volume><year>2006</year><fpage>1129</fpage><lpage>1140</lpage><pub-id pub-id-type="pmid">16959053</pub-id></element-citation></ref><ref id="bb0120"><label>24</label><element-citation publication-type="journal" id="rf0120"><person-group person-group-type="author"><name><surname>Grant</surname><given-names>W.B.</given-names></name></person-group><article-title>Variations in vitamin D production could possibly explain the seasonality of childhood respiratory infections in Hawaii</article-title><source>Pediatr Infect Dis J</source><volume>27</volume><year>2008</year><fpage>853</fpage></element-citation></ref><ref id="bb0125"><label>25</label><element-citation publication-type="journal" id="rf0125"><person-group person-group-type="author"><name><surname>Vasarhelyi</surname><given-names>B.</given-names></name><name><surname>Satori</surname><given-names>A.</given-names></name><name><surname>Olajos</surname><given-names>F.</given-names></name><name><surname>Szabo</surname><given-names>A.</given-names></name><name><surname>Beko</surname><given-names>G.</given-names></name></person-group><article-title>Low vitamin D levels among patients at Semmelweis University: retrospective analysis during a one-year period</article-title><source>Orv Hetil</source><volume>152</volume><year>2011</year><fpage>1272</fpage><lpage>1277</lpage><pub-id pub-id-type="pmid">21803724</pub-id></element-citation></ref><ref id="bb0130"><label>26</label><element-citation publication-type="journal" id="rf0130"><person-group person-group-type="author"><name><surname>Zijian</surname><given-names>F.</given-names></name><name><surname>Qun</surname><given-names>L.</given-names></name><name><surname>Yanping</surname><given-names>Z.</given-names></name></person-group><article-title>The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China</article-title><source>China CDC Weekly</source><volume>2</volume><year>2020</year><fpage>113</fpage><lpage>122</lpage></element-citation></ref><ref id="bb0135"><label>27</label><element-citation publication-type="journal" id="rf0135"><person-group person-group-type="author"><name><surname>Bergman</surname><given-names>P.</given-names></name><name><surname>Lindh</surname><given-names>&#x000c5;.U.</given-names></name><name><surname>Bj&#x000f6;rkhem-Bergman</surname><given-names>L.</given-names></name><name><surname>Lindh</surname><given-names>J.D.</given-names></name></person-group><article-title>Vitamin D and respiratory tract infections: a systematic review and meta-analysis of randomized controlled trials</article-title><source>PLoS One</source><volume>8</volume><year>2013</year><fpage>1</fpage><lpage>4</lpage></element-citation></ref><ref id="bb0140"><label>28</label><element-citation publication-type="journal" id="rf0140"><person-group person-group-type="author"><name><surname>Rhodes</surname><given-names>J.M.</given-names></name><name><surname>Subramanian</surname><given-names>S.</given-names></name><name><surname>Laird</surname><given-names>E.</given-names></name><name><surname>Kenny</surname><given-names>R.A.</given-names></name></person-group><article-title>Editorial: low population mortality from COVID-19 in countries south of 35 degrees North supports vitamin D as a factor determining severity, Aliment. Pharmacol</article-title><source>Ther.</source><year>2020</year><fpage>1</fpage><lpage>4</lpage></element-citation></ref><ref id="bb0145"><label>29</label><element-citation publication-type="journal" id="rf0145"><person-group person-group-type="author"><name><surname>Daneshkhah</surname><given-names>A.</given-names></name><name><surname>Eshein</surname><given-names>A.</given-names></name><name><surname>Subramanian</surname><given-names>H.</given-names></name><name><surname>Roy</surname><given-names>H.K.</given-names></name><name><surname>Backman</surname><given-names>V.</given-names></name></person-group><article-title>The Role of Vitamin D in Suppressing Cytokine Storm in COVID-19 Patients and Associated Mortality</article-title><source>medRxiv</source><year>2020</year></element-citation></ref><ref id="bb0150"><label>30</label><element-citation publication-type="journal" id="rf0150"><person-group person-group-type="author"><name><surname>Qin</surname><given-names>C.</given-names></name><name><surname>Zhou</surname><given-names>L.</given-names></name><name><surname>Hu</surname><given-names>Z.</given-names></name></person-group><article-title>Dysregulation of Immune Response in Patients with COVID-19 in Wuhan, China</article-title><source>Clin Infect Dis</source><year>2020</year></element-citation></ref><ref id="bb0155"><label>31</label><element-citation publication-type="journal" id="rf0155"><person-group person-group-type="author"><name><surname>Lau</surname><given-names>F.H.</given-names></name><name><surname>Majumder</surname><given-names>R.</given-names></name><name><surname>Torabi</surname><given-names>R.</given-names></name></person-group><article-title>Vitamin D insufficiency is prevalent in severe COVID-19</article-title><source>medRxiv</source><year>2020</year></element-citation></ref><ref id="bb0160"><label>32</label><element-citation publication-type="book" id="rf0160"><person-group person-group-type="author"><name><surname>Alipio</surname><given-names>M.</given-names></name></person-group><chapter-title>Vitamin D Supplementation Could Possibly Improve Clinical Outcomes of Patients Infected with Coronavirus-2019 (COVID-19)</chapter-title><comment>Available at SSRN 3571484</comment><year>2020</year></element-citation></ref><ref id="bb0165"><label>33</label><element-citation publication-type="journal" id="rf0165"><person-group person-group-type="author"><name><surname>Ross</surname><given-names>A.C.</given-names></name><name><surname>Manso</surname><given-names>J.E.</given-names></name><name><surname>Abrams</surname><given-names>S.A.</given-names></name></person-group><article-title>The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know</article-title><source>J Clin Endocrinol Metab</source><volume>96</volume><year>2011</year><fpage>53</fpage><lpage>58</lpage><pub-id pub-id-type="pmid">21118827</pub-id></element-citation></ref><ref id="bb0170"><label>34</label><element-citation publication-type="journal" id="rf0170"><person-group person-group-type="author"><name><surname>Quraishi</surname><given-names>S.A.</given-names></name><name><surname>Bittner</surname><given-names>E.A.</given-names></name><name><surname>Blum</surname><given-names>L.</given-names></name><name><surname>Hutter</surname><given-names>M.M.</given-names></name><name><surname>Camargo</surname><given-names>C.A.</given-names><suffix>Jr.</suffix></name></person-group><article-title>Association between preoperative 25-hydroxyvitamin D level and hospital-acquired infections following Roux-en-Y gastric bypass surgery</article-title><source>JAMA Surg</source><volume>149</volume><year>2014</year><fpage>112</fpage><lpage>118</lpage><pub-id pub-id-type="pmid">24284777</pub-id></element-citation></ref><ref id="bb0175"><label>35</label><element-citation publication-type="journal" id="rf0175"><person-group person-group-type="author"><name><surname>Sabetta</surname><given-names>J.R.</given-names></name><name><surname>DePetrillo</surname><given-names>P.</given-names></name><name><surname>Cipriani</surname><given-names>R.J.</given-names></name></person-group><article-title>Serum 25-hydroxyvitamin d and the incidence of acute viral respiratory tract infections in healthy adults</article-title><source>PLoS One</source><volume>5</volume><year>2010</year><object-id pub-id-type="publisher-id">e11088</object-id></element-citation></ref><ref id="bb0180"><label>36</label><element-citation publication-type="journal" id="rf0180"><person-group person-group-type="author"><name><surname>Heaney</surname><given-names>R.P.</given-names></name><name><surname>Davies</surname><given-names>K.M.</given-names></name><name><surname>Chen</surname><given-names>T.C.</given-names></name></person-group><article-title>Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol</article-title><source>Am J Clin Nutr</source><volume>77</volume><year>2003</year><fpage>204</fpage><lpage>210</lpage><pub-id pub-id-type="pmid">12499343</pub-id></element-citation></ref><ref id="bb0185"><label>37</label><element-citation publication-type="journal" id="rf0185"><person-group person-group-type="author"><name><surname>Charoenngam</surname><given-names>N.</given-names></name><name><surname>Shirvani</surname><given-names>A.</given-names></name><name><surname>Kalajian</surname><given-names>T.A.</given-names></name><name><surname>Song</surname><given-names>A.</given-names></name><name><surname>Holick</surname><given-names>M.F.</given-names></name></person-group><article-title>The Effect of Various Doses of Oral Vitamin D3 Supplementation on Gut Microbiota in Healthy Adults: A Randomized, Double-blinded, Dose-response Study</article-title><source>Anticancer Res</source><volume>40</volume><year>2020</year><fpage>551</fpage><lpage>556</lpage><pub-id pub-id-type="pmid">31892611</pub-id></element-citation></ref></ref-list></back></article>